As the primary care provider or physician specialist, you may desire additional support and scientific information about Neuropsychiatric Disorders testing. Please let us know how we can help you. Neuropsychiatric Disorders are neurologic and autoimmune conditions which have been clinically identified and studied for a number of years. Basic and clinical research are being conducted globally to better treat, diagnose and understand these diseases. As additional peer-reviewed studies are published, we will add them to our Digital Library.

Our sincere goal is to aid you by providing independent testing results as you seek to diagnose and treat your patients with these conditions. A general overview of Neuropsychiatric Disorders along with information about published treatment studies are discussed in the Neuropsychiatric Disorders overview section of this website. References are cited to allow you the opportunity to read more about these diseases at your discretion. Many articles are referenced and abstracts provided in the Digital Library section of this website.

Moleculera Labs Prescriber Portal

Prescriber Portal

The secure Prescriber Portal for prescribers allows you place an order and to retrieve and review the test results of your patients.
Diagnosis and Treatment PANS and PANDAS

Diagnosis and Treatment

PANS and PANDAS are clinical diagnosis and based on whether presenting symptoms meet the diagnostic criteria, as set forth by National Institute of Mental Health (NIMH). Recognizing PANS/PANDAS can be challenging even for the most skilled clinicians.
PANDAS Diagnostic Criteria

PANDAS Diagnostic Criteria

PANDAS is a clinical diagnosis based on 5 distinct criteria as developed by the NIMH and listed below. Currently there are no definitive diagnostic laboratory tests for PANDAS, but the Cunningham Panel™ is the first and only test that was developed specifically as an aid to doctors in making their diagnosis.
PANS Diagnostic Criteria

PANS Diagnostic Criteria

PANS is diagnosed based on clinical presentations. Since symptoms overlap with other medical conditions, PANS can be difficult to identify. However, an early diagnosis and prompt treatment can prevent the significant toll that the symptoms and behavioral changes have on children and their families.
Physician Educational Series

Physician Educational Series

Moleculera Labs provides medical professionals with an online educational series featuring the latest news, peer-reviewed journal articles, and video presentations on molecular mimicry and post-infectious autoimmune encephalopathies, including PANS and PANDAS.
Physician Education Opportunities

Physician Education Opportunities

Numerous studies have shown that immune system dysfunction can contribute to the development of CNS disorders, including autoimmune neuropsychiatric syndromes PANS and PANDAS. This section provides links to online educational courses in the field of neuroimmunology.
Order Brochures For Your Office

Order Brochures For Your Office

As a healthcare provider, you may order brochures in bulk for your office and to handout to your patients.
Ordering Lab Tests for PANS and PANDAS

Ordering Lab Tests

The Cunningham Panel™ of tests requires a physician order before we can receive and process any specimen. We have a secure Prescriber Portal for prescribers to place an order and to retrieve and review the test results of your patients.
International Ordering Cunningham Panel

International Orders

Prescribers practicing outside the United States and Canada, please visit our International Ordering page for more information.
Physician FAQs about PANS and PANDAS

Physician FAQs

The purpose of the Cunningham Panel™ is to provide laboratory results to physicians as an aid in their diagnosis of PANS and PANDAS. Learn more through our Physicians Frequently Asked Questions.
Educational videos about PANS and PANDAS

Educational Video Library

Educational videos about PANS and PANDAS from leaders in the field.
Journal of Child and Adolescent Psychopharmacology - latest research on PANS and PANDAS

JCAP Journal Articles

The Journal of Child and Adolescent Psychopharmacology published a special edition, in February 2015, featuring the latest research on PANS and PANDAS.
Physician Digital Library PANS and PANDAS

Digital Library

The Moleculera Labs digital library is a comprehensive resource used by health professionals to find the most recent peer-reviewed studies on PANS and PANDAS.


Moleculera Labs has designed brochures for both parents and physicians to assist in making a Neuropsychiatric Disorder Diagnosis or a PANS/PANDAS diagnosis as well as a brochure answering frequently asked questions about insurance coverage for The Cunningham Panel™. As a healthcare provider, you may order brochures in bulk for your office and to handout to your patients. Click below to order or to download these brochures.

B. Robert Mozayeni, MD

Medical and Clinical Advisor

B. Robert Mozayeni MD

Dr. B. Robert Mozayeni was trained in Internal Medicine and Rheumatology at Yale and at NIH. He has had pre- and post-doctoral Fellowships in Molecular Biophysics and Biochemistry at Yale, and also at NIH where he was a Howard Hughes Research Scholar at LMB/DCBD/NCI and later, Senior Staff Fellow at LMMB/NHLBI/NIH. Editorial board of Infectious Diseases – Surveillance, Prevention and Treatment. Past President of the International Lyme and Associated Diseases Society (ILADS).

He is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently. He is a Fellow of the non-profit Think Lead Innovate Foundation and is a co-founder of the Foundation for the Study of Inflammatory Diseases. He is a Founder of the Foundation for the Study of Inflammatory Diseases to crowd-source medical solutions for complex conditions using existing knowledge, diagnostic methods, and therapies to meet patient needs immediately. He is the Chief Medical Officer of Galaxy Diagnostics, LLC. He is a Board member of the Human-Kind Alliance. Dr. Mozayeni has held admitting privileges (since 1994) on the clinical staff of Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the National Institutes of Health Clinical Center.

Safedin Sajo Beqaj, PhD, HCLD, CC (ABB)

Moleculera Labs, Clinical Laboratory Advisor
Medical Database, Inc., President and CEO

Sajo Baqaj, PhD

Dr. Sajo Beqaj is board certified in molecular pathology and genetics and licensed as a Bioanalyst and High Complexity Laboratory Director. He has been practicing as a laboratory director since 2005.

Dr. Beqaj served as a technical director and was part of the initial management team for several well-known laboratories in the clinical lab industry including PathGroup, Nashville, TN; DCL Medical Laboratories, Indianapolis, IN, and Pathology, Inc, Torrance, CA. He is currently serving as off-side CLIA laboratory director for BioCorp Clinical Laboratory, Whittier, CA and Health360 Labs, Garden Grove, CA.

Dr. Beqaj received his Ph.D. in Pathology from Wayne State University Medical School, Detroit, Michigan. He performed his post-doctoral fellowship at Abbott Laboratories from 2001-2003 and with Children’s Hospital and Northwestern University from 2003-2005.

Dr. Beqaj has taught in several academic institutions and has published numerous medical textbook chapters and journal articles. He has served as a principal investigator in clinical trials for several well-known pharmaceutical and diagnostic companies such as Roche HPV Athena, Merck HPV vaccine, BD vaginitis panel, Roche (Vantana) CINtec® Histology clinical trials, and has presented various scientific clinical abstracts and presentations.

He is a member of several medical and scientific associations including the Association of Molecular Pathology, American Association of Clinical Chemistry and the Pan Am Society for Clinical Virology. He has served on a number of clinical laboratory regulatory and scientific committees, and has assisted several laboratories and physicians as a Clinical Laboratory Consultant.

Rodney Cotton, MBA

Moleculera Labs Board Member

Rodney Cotton, MBA

Rodney Cotton, MBA is an entrepreneurial thought leader in the pharmaceutical/biotech industry who is known for his holistic perspective, bias for action in the face of challenges, and commitment to agile processes.

Rod is an independent director for Orchard Software, a private equity-backed health technology company owned by Francisco Partners; an advisory board member to Flo2 Ventures, a venture capital-backed healthcare and health equity accelerator; and a member of the board of directors and three board committees (Audit, Compliance & Finance; Governance & Equity; and Quality of Care) for Community Health Network.

He built a successful career at Roche spanning more than two decades and culminating in the role of SVP, Head of Strategy & Transformation, and Chief of Staff to the CEO for Roche Diagnostics, the North American headquarters of the world’s largest ($17B) diagnostics company.

While at Roche, Rod led key enterprise initiatives, such as milestone corporate communications, health equity coalitions, the US/Roche Group audit, and global/US acquisition integrations. With 40+ years of experience, he drove the financial turnaround and cultural transformation of four global healthcare companies, led teams of up to 280 total reports, managed P&L of more than $1 billion, and served as a key member of the senior leadership team executing the most significant restructuring of the company in two decades.

In the face of the COVID-19 pandemic, Rod and his team at Roche accelerated six ground breaking products in 11 months, including the first launch of the market’s most accurate and in demand molecular diagnostic test. He also solved extraordinary challenges of product scarcity, supply chain, product allocation, and logistics to achieve accelerated global sourcing and self manufacturing in line with testing guidelines.

A frequent public speaker on health equity and other topics, Rod was named one of the Most Influential Black Executives in Corporate America by Savoy Magazine and one of the Top Blacks in Healthcare by He also received The Sagamore of the Wabash Award, one of the highest Indiana State honors, bestowed by Indiana Governor Eric J. Holcomb.

Rod holds an M.B.A. from California State University, Dominguez Hills, an M.S. in Strategic Management from the University of Southern California, and a B.A. in Biological Sciences & Technology from the University of California at Santa Barbara.